Medtronic PLC closed 14.93% below its 52-week high of $96.25, which the company reached on March 10th.

Medtronic PLC closed 8.69% short of its 52-week high of $96.25, which the company reached on March 10th.

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

According to Benzinga Pro, Medtronic's peer group average for short interest as a percentage of float is 4.55%, which means ...

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

Medtronic’s latest recall of the Pipeline Vantage 027 and 021 products is likely to result in revenue losses in the ...

Today's Research Daily features new research reports on 12 major stocks, including Mastercard Incorporated (MA), Medtronic ...

Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic has reported late-breaking data from the Evolut Low Risk Trial’s five-year outcomes of the Evolut TAVR system.

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.